COLOMA JASON V (Chief Executive Officer) sold 15.3% of their position (34.50K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $932.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/2/2026ACC: 0001676170-26-000024
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-34.50K
Net shares
Net seller
$932.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
34.50K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2.59K
Price / share
$27.02
Trade value
$70.07K
% of position
14.3%
10/1/2026
18.15K→15.56K
Common Stock
Indirect
Shares
−31.91K
Price / share
$27.02
Trade value
$862.19K
% of position
14.3%
10/1/2026
223.35K→191.45K
Total
Net shares
−34.50K
Net value
-$932.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/1/2026 | S · Sale | −2.59K | $27.02 | $70.07K | 14.3% | 18.15K | 15.56K |
| Common Stock Indirect | 10/1/2026 | S · Sale | −31.91K | $27.02 | $862.19K | 14.3% | 223.35K | 191.45K |
| Total | −34.50K | -$932.26K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned27.36K
Total
27.36K direct27.36K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.36K | Direct |
| Total | 27.36K | 27.36K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported